Prevention and Intervention of Overweight and Obesity in Preschool Children

August 16, 2024 updated by: Chen Li

Research on Prevention and Intervention of Overweight and Obesity in Preschool Children

Obesity is an important public health problem, which is directly related to the risk of childhood complications and the increase of incidence rate and mortality of adult complications. The consequences are more serious than malnutrition such as low weight. Since the 1980s, the obesity rate among children in China has gradually increased. Currently, overweight and obesity are important health issues for children in rural and urban areas of China, with obesity rates in many large cities approaching or exceeding those in developed countries. The Report on Nutrition and Chronic Disease Status of Chinese Residents (2020) shows that the overweight and obesity rate among children aged 6-17 in China has approached 20%, with 10% of children under 6 years old. The imbalance between energy intake and expenditure is the direct cause of individual overweight and obesity. The 2021 "Healthy Children Action Plan (2021-2025)" explicitly requires the implementation of early screening, early diagnosis, and early treatment prevention and control strategies for risk factors such as obesity that seriously endanger children's health, reducing disease burden, promoting children's health, emphasizing the principle of prevention first and combining prevention and treatment. Given the current status of children's nutrition and health in China, it is an urgent need to establish a standardized and regulated monitoring and management system for obesity and overweight in preschool children, as well as service standards, for the development of children's health. This project aims to establish a complete prevention, improvement, and intervention promotion plan for obesity and overweight in preschool children, as well as a comprehensive monitoring and management system that combines medicine, education, home, and community. It will strengthen children's nutrition feeding and exercise guidance, reduce sedentary time, promote food and movement balance, and prevent and reduce childhood overweight and obesity. Provide children with comprehensive, full process, and warm children's healthcare clothing, and provide small-scale policy research references for the implementation of support systems for children's nutrition improvement projects.

Study Overview

Detailed Description

  1. Procedures. Step 1: Epidemiological survey: Conduct a health survey on preschool children in selected kindergartens to understand the prevalence and risk factors of overweight and obese children; Phase 2: Recruit overweight and obese children from kindergartens with a population of over 200 in Chongqing, and randomly divide them into an intervention group and a blank control group. Dietary and exercise management, combined with reward and support mechanism monitoring, were implemented for the intervention group, while the blank control group did not receive the aforementioned interventions. Measure the height, weight, BMI, questionnaire survey, blood indicators, etc. of the children before and after the intervention, and use them as evaluation indicators.
  2. The sample size for comparing the means of the two groups is N=(Z α/2+Z β) 2 σ 2 (Q1-1+Q2-1)/δ 2. If the difference in BMI decrease between the two groups after intervention is 0.58, and if σ=1.2 and α is taken as 0.05 on both sides, the test power is 0.8, Q1=Q2=0.5,σ=1.2,δ=0.58,Z0.05/2=1.96,Zβ=0.842, Calculate N=(1.96+0.842) 2 * 1.22 * (0.5-1+0.5-1)/0.582 ≈ 69, taking into account the situation of loss to follow-up and refusal to follow up at 20%. The final required two groups of research subjects are 87, and a total of at least 174 research subjects will be included.

4. Statistical analysis. SPSS 26.0 software was used for statistical analysis, and descriptive statistics were performed on general demographic data. Count data was expressed as n (%), and inter group comparisons of rates were performed using a 2-test. Continuous variables that followed a normal distribution were described as mean ± standard deviation (x ± s), and inter group comparisons were performed using t-test. All tests were two-sided, and the test level α was set to 0.05. Multivariate logistic regression analysis of the correlation between nutritional status and risk factors. Using rank sum test to compare the differences in various indicators before and after intervention in obese and overweight children.

5.Ethical matters and data protection. The patients participated in the study will sign the informed consent (obtained from the guardian). And this study was approved by the local ethics committee. Patient's name will be abbreviated and the research data will be assigned a code then to provide to the researcher. The authorization from parents on the patient's health information remains valid until the study is completed. After that, researchers will delete private information from the study record.

Study Type

Interventional

Enrollment (Estimated)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chongqing, China
        • Recruiting
        • Children's Hospital of Chongqing Medical University
        • Contact:
        • Contact:
    • Chongqing
      • Chongqing, Chongqing, China, 400014
        • Recruiting
        • Growth,Development and Mental Health of Children and Adolescents Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

overweight or obese Children Currently, there are no projects related to overweight and obesity management (such as weight loss management, etc.) Parents and children are willing to accept dietary and exercise management for a period of 4 months Willing to measure height, weight, BMI, blood pressure, body composition, questionnaire survey (exercise, diet, etc.) and other items before intervention and 1 month, 2 months, 3 months, and 4 months after intervention (a total of 5 times) Willing to undergo blood tests before and 4 months after intervention (2 times in total); The questionnaire information is filled in accurately and meets the questionnaire quality control standards

Exclusion Criteria:

Recruiter exclusion criteria:

Preschool children with underlying diseases (such as congenital heart disease, liver and kidney disease, thyroid disease, malignant tumors, etc.) or uncontrolled underlying diseases

Questionnaire exclusion criteria:

Incorrect information filling in the questionnaire, which does not meet the questionnaire quality control standards

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The overweight and obese children aged 3-6 years old,receive dietary and exercise management, combined reward support mechanisms.
Dietary and exercise management: dietary management by providing tailored recipes, health education lectures, science competitions, etc;exercise management:develop weekly and monthly exercise plans for children of different ages, and have physical education teachers lead them in exercising.
Active Comparator: Control group
The overweight and obese children aged 3-6 years old only receive basic health guidance,do not receive dietary and exercise management nor combined reward support mechanisms like experimental group.
NO dietary and exercise management:do not implement dietary and exercise management related to the experimental group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: 3-4 months
Changes in BMI between the experimental group and intervention group at the beginning and end of the project
3-4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition--Fat (%)
Time Frame: 3-4 months
Changes in Body composition including Fat (%) between the experimental group and intervention group at the beginning and end of the project.
3-4 months
Body composition--Body fat index (BFMI)
Time Frame: 3-4 months
Changes in Body composition including Body fat index (BFMI) between the experimental group and intervention group at the beginning and end of the project.
3-4 months
Body composition--Fat-free mass index (FFMI)
Time Frame: 3-4 months
Changes in Body composition including Fat-free mass index (FFMI) between the experimental group and intervention group at the beginning and end of the project.
3-4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
questionnaire investigation
Time Frame: 3-4 months
Changes in questionnaire investigation(involving diet, exercise, and obesity awareness) between the experimental group and intervention group at the beginning and end of the project
3-4 months
Blood indicators--ALT
Time Frame: 3-4 months
Changes in blood indicators including glutamic-pyruvic transaminase (ALT) between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--AST
Time Frame: 3-4 months
Changes in blood indicators including glutamic-oxaloacetic transaminase(AST) between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--creatinine
Time Frame: 3-4 months
Changes in blood indicators including creatinine between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--uric acid
Time Frame: 3-4 months
Changes in blood indicators including uric acid between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--urea
Time Frame: 3-4 months
Changes in blood indicators including urea between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--blood sugar
Time Frame: 3-4 months
Changes in blood indicators including blood sugar between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--triglyceride
Time Frame: 3-4 months
Changes in blood indicators including triglyceride between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--cholesterol
Time Frame: 3-4 months
Changes in blood indicators including cholesterol between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--high-density
Time Frame: 3-4 months
Changes in blood indicators including high-density lipoprotein between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--low density lipoprotein
Time Frame: 3-4 months
Changes in blood indicators including low density lipoprotein between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--VD
Time Frame: 3-4 months
Changes in blood indicators including VD between the experimental group and intervention group at the beginning and end of the of the project.
3-4 months
Blood indicators--VA
Time Frame: 3-4 months
cators including VA between the experimental group and intervention group
3-4 months
Blood indicators--ferritin
Time Frame: 3-4 months
cators including ferritin between the experimental group and intervention group
3-4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

July 11, 2024

First Submitted That Met QC Criteria

August 16, 2024

First Posted (Actual)

August 20, 2024

Study Record Updates

Last Update Posted (Actual)

August 20, 2024

Last Update Submitted That Met QC Criteria

August 16, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data is confidential during the study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on dietary and exercise management

Subscribe